These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 15199945)

  • 1. A comparative study of quantitative structure-activity relationship methods based on gallic acid derivatives.
    Huang H; Ou W; Zhao J; Chen D; Wang L
    SAR QSAR Environ Res; 2004 Apr; 15(2):83-99. PubMed ID: 15199945
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CoMFA and HQSAR studies on 6,7-dimethoxy-4-pyrrolidylquinazoline derivatives as phosphodiesterase10A inhibitors.
    Kulkarni SS; Patel MR; Talele TT
    Bioorg Med Chem; 2008 Apr; 16(7):3675-86. PubMed ID: 18299198
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hologram quantitative structure activity relationship studies on 5-HT6 antagonists.
    Doddareddy MR; Lee YJ; Cho YS; Choi KI; Koh HY; Pae AN
    Bioorg Med Chem; 2004 Jul; 12(14):3815-24. PubMed ID: 15210148
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 3D QSAR studies of 1,3,4-benzotriazepine derivatives as CCK2 receptor antagonists.
    Kaur K; Talele TT
    J Mol Graph Model; 2008 Nov; 27(4):409-20. PubMed ID: 18774323
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 3D-QSAR CoMFA/CoMSIA studies on 5-aryl-2,2-dialkyl-4-phenyl-3(2H)-furanone derivatives, as selective COX-2 inhibitors.
    Puntambekar DS; Giridhar R; Yadav MR
    Acta Pharm; 2006 Jun; 56(2):157-74. PubMed ID: 16613723
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Holographic quantitative structure-activity relationship for prediction acute toxicity of benzene derivatives to the guppy (Poecilia reticulata).
    Huang H; Wang XD; Dai XL; Yu YJ; Wang LS
    J Environ Sci (China); 2004; 16(3):423-7. PubMed ID: 15272716
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Hologram quantitative structure-activity relationship for predicting acute toxicity of benzene derivatives to the tadpoles (Rana japonica)].
    Huang H; Yang H; Fan W; Wang LS
    Huan Jing Ke Xue; 2005 May; 26(3):25-8. PubMed ID: 16124464
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mapping the binding site of a large set of quinazoline type EGF-R inhibitors using molecular field analyses and molecular docking studies.
    Hou T; Zhu L; Chen L; Xu X
    J Chem Inf Comput Sci; 2003; 43(1):273-87. PubMed ID: 12546563
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 3D-QSAR CoMFA/CoMSIA studies on Urokinase plasminogen activator (uPA) inhibitors: a strategic design in novel anticancer agents.
    Bhongade BA; Gadad AK
    Bioorg Med Chem; 2004 May; 12(10):2797-805. PubMed ID: 15110861
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 3D QSAR studies on protein tyrosine phosphatase 1B inhibitors: comparison of the quality and predictivity among 3D QSAR models obtained from different conformer-based alignments.
    Pandey G; Saxena AK
    J Chem Inf Model; 2006; 46(6):2579-90. PubMed ID: 17125198
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Understanding the antitumor activity of novel tricyclicpiperazinyl derivatives as farnesyltransferase inhibitors using CoMFA and CoMSIA.
    Puntambekar DS; Giridhar R; Yadav MR
    Eur J Med Chem; 2006 Nov; 41(11):1279-92. PubMed ID: 16919851
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Three-dimensional quantitative structure-activity relationship study for phenylsulfonyl carboxylates using CoMFA and CoMSIA.
    Liu X; Yang Z; Wang L
    Chemosphere; 2003 Dec; 53(8):945-52. PubMed ID: 14505717
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Holographic QSAR of selected esters.
    Chen D; Yin C; Wang X; Wang L
    Chemosphere; 2004 Dec; 57(11):1739-45. PubMed ID: 15519421
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CoMFA and HQSAR of acylhydrazide cruzain inhibitors.
    Rodrigues CR; Flaherty TM; Springer C; McKerrow JH; Cohen FE
    Bioorg Med Chem Lett; 2002 Jun; 12(11):1537-41. PubMed ID: 12031337
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Quantitative structure-activity relationships for a series of selective estrogen receptor-beta modulators.
    Salum LB; Polikarpov I; Andricopulo AD
    SAR QSAR Environ Res; 2007; 18(7-8):711-27. PubMed ID: 18038369
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Two- and three-dimensional quantitative structure-activity relationships for a series of purine nucleoside phosphorylase inhibitors.
    Castilho MS; Postigo MP; de Paula CB; Montanari CA; Oliva G; Andricopulo AD
    Bioorg Med Chem; 2006 Jan; 14(2):516-27. PubMed ID: 16203153
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 3D QSAR comparative molecular field analysis on nonsteroidal farnesoid X receptor activators.
    Honório KM; Garratt RC; Polikarpov I; Andricopulo AD
    J Mol Graph Model; 2007 Mar; 25(6):921-7. PubMed ID: 17055759
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hologram quantitative structure-activity relationships for a series of farnesoid X receptor activators.
    Honorio KM; Garratt RC; Andricopulo AD
    Bioorg Med Chem Lett; 2005 Jun; 15(12):3119-25. PubMed ID: 15893927
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 3D-QSAR studies on triclosan derivatives as Plasmodium falciparum enoyl acyl carrier reductase inhibitors.
    Shah P; Siddiqi MI
    SAR QSAR Environ Res; 2010 Jul; 21(5-6):527-45. PubMed ID: 20818586
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular docking and QSAR studies on substituted acyl(thio)urea and thiadiazolo [2,3-alpha] pyrimidine derivatives as potent inhibitors of influenza virus neuraminidase.
    Sun J; Cai S; Mei H; Li J; Yan N; Wang Q; Lin Z; Huo D
    Chem Biol Drug Des; 2010 Sep; 76(3):245-54. PubMed ID: 20626407
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.